Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lipocine Inc.
Public Company Edition: Three companies postponed or withdrew their offerings, but drug developers continue to pursue IPOs. Also, Biocon, BMS and Epizyme raised money through new debt, Five Prime capitalized on positive data and Synthetic Biologic engaged a strategic advisor.
The latest drug development news and highlights from the Pink Sheet FDA Performance Tracker.
Keeping Track Of User Fee Decisions And Filings: Adakveo, Brukinsa And Fetroja Mark Massive Week Of Novel Approvals
The latest news on US FDA user fee decisions and submissions to the agency.
The latest drug development news and highlights from our US FDA Performance Tracker.
- Specialty Pharmaceuticals
- Controlled Release
- Large Molecule
Drug Discovery Tools